Article citationsMore>>

K. M. Leu, L. J. Ostruszka, D. Shewach, et al., “Laboratory and Clinical Evidence of Synergistic Cytotoxicity of Sequential Treatment with Gemcitabine Followed by Docetaxel in the Treatment of Sarcoma,” Journal of Clinical Oncology, Vol. 22, No. 9, 2004, pp. 1706-1712. doi:10.1200/JCO.2004.08.043

has been cited by the following article:

• TITLE: Metastatic Primary Pulmonary Angiosarcoma

  AUTHORS: Brendan F. Judy, Jarrod D. Predina, Jay Mittal, Charuhas Deshpande, Sunil Singhal

  KEYWORDS: Angiosarcoma; Pulmonary; Tumor; Surgery

  JOURNAL NAME: Surgical Science, Vol.2 No.3, May 18, 2011

  ABSTRACT: Angiosarcoma is an extremely aggressive tumor with a high rate of mortality. It can arise in any tissue of the body and is most commonly found in the skin and soft tissue[1]. Pulmonary angiosarcoma is usually secondary to a primary location of the body and presents as both solitary and multiple nodules. Primary pulmonary angiosarcoma is a rare disease with less than 20 cases reported in the English literature. In our report we present a case of metastatic primary pulmonary angiosarcoma involving the most ( > 100) pulmonary nodules known to date. Novel treatment strategy using an anti-angiogenic inhibitor was used to treat this disease for the first time to our knowledge; however, it was unsuccessful in controlling disease progression. This report reviews the literature of this rare and devastating disease.